Company Comparison
Evelo Biosciences vs BioDefense Pro
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Evelo Biosciences | BioDefense Pro |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, Massachusetts | Cambridge |
| Founded | 2014 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Seed |
| Total Funding | $260M | $11M |
| Valuation | — | — |
What They Build
Evelo Biosciences
Clinical-stage biotechnology company developing oral therapies that modulate the gut microbiome to treat inflammatory diseases.
BioDefense Pro
A Cambridge-based biotech company developing biotechnology solutions for biodefense and biosecurity applications.
Key Investors
Evelo Biosciences
BioDefense Pro
No investors listed.
Sector Overlap
Both Evelo Biosciences and BioDefense Pro operate in Biotech.
Browse all Biotech companies →The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
14-day free trial. No credit card required.